Bausch + Lomb (BLCO) Corporatio announced the European launch of the Bi-Blade+ advanced dual-port vitrectomy cutter on the Stellaris Elite Vision Enhancement System. “The launch of Bi-Blade+ is the latest example of our commitment to delivering meaningful innovation in Europe,” said Luc Bonnefoy, president, Surgical, Bausch + Lomb. “Stellaris Elite has long been relied upon by European surgeons, and the 2024 Adaptive Fluidics software upgrade further enhanced the precise control and efficiency of the platform. We’re confident that the addition of Bi-Blade+ will also deliver meaningful benefits to retina surgeons and their patients.”
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BLCO:
- Bausch + Lomb Lifts Outlook After Margin-Heavy Quarter
- Bausch + Lomb price target lowered to $16 from $17 at Evercore ISI
- Bausch + Lomb price target lowered to $16 from $18 at Deutsche Bank
- Bausch + Lomb price target lowered to C$19 from C$21 at Citi
- Bausch + Lomb: Solid Q1 Beat and Pharma Momentum Offset by Spin-Off Uncertainty, Supporting Hold Rating